Which ivermectin topical formulation (0.5% ivermectin lotion, brand Sklice) is appropriate for treating head lice in a 7‑year‑old child who meets the weight requirement?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ivermectin 0.5% Lotion (Sklice) is Appropriate for Head Lice Treatment in a 7-Year-Old

For a 7-year-old child meeting weight requirements, use ivermectin 0.5% lotion (Sklice) as a single 10-minute application to dry hair, then rinse—no nit combing or second application required. This formulation is FDA-approved for children 6 months and older and demonstrates superior efficacy compared to vehicle control 1, 2.

Application Protocol

Apply the lotion to completely dry hair and scalp, ensuring thorough coverage. Leave on for exactly 10 minutes, then rinse with water over a sink (not shower/bath) using warm water to minimize systemic absorption 1. The product works by causing pharyngeal muscle paralysis in lice, preventing feeding, and kills both live lice and emerging nymphs from treated eggs 3.

Efficacy Data

The pivotal trials demonstrated that 73.8% of patients remained louse-free at day 15 after a single application, compared to only 17.6% with vehicle control (P<0.001) 2. While this cure rate is lower than some alternatives like spinosad (0.9%) or benzyl alcohol (5%), the single-application convenience and excellent tolerability profile make it a practical choice 3.

Safety Considerations

Critical safety points:

  • Approved for ages 6 months and older 1
  • Keep eyes tightly closed during application; protect with washcloth 1
  • Do NOT use in eyes, nose, mouth, vagina, or on eyebrows/eyelashes 1
  • Minimal systemic absorption occurs (plasma concentrations <1 ng/mL in children as young as 6 months) 4
  • Most common adverse effects: pruritus (0.9%), erythema, dandruff, dry skin 2, 3

When to Consider Alternatives

The 2010 AAP guidelines position ivermectin as investigational, noting it was "not currently approved by the FDA as a pediculicide" at that time 5. However, Sklice received FDA approval subsequently. The guidelines recommend:

First-line: Permethrin 1% or pyrethrins [@1-10@]

Second-line (for documented resistance or treatment failure): Malathion 0.5% for children ≥24 months 5

Third-line: Ivermectin (now FDA-approved), benzyl alcohol 5%, or spinosad 3

Common Pitfalls to Avoid

  • Do not apply to wet hair—the lotion must be applied to dry hair for proper efficacy
  • Do not use conditioning shampoos before application—silicone-based additives impair product adherence 5
  • Do not confuse with oral ivermectin—the topical 0.5% lotion requires only one application versus oral dosing which needs repeat treatment and has weight restrictions (≥15 kg) 5
  • Persistent itching is not treatment failure—scalp irritation can persist for days after lice are killed and does not indicate need for retreatment 5

Practical Advantage

Unlike permethrin (which requires retreatment on day 9) or benzyl alcohol (requires two applications 7 days apart), ivermectin 0.5% lotion achieves eradication with a single 10-minute treatment 2, 3. This improves adherence, particularly important given that improper application is the most common cause of treatment failure 5.

The product is now available over-the-counter, though cost may be a limiting factor compared to generic permethrin 1, 3.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.